The EU Cosmetics Directive stipulates that product data have to be kept readily accessible for all cosmetic products which are on the European market. An important part of this product information is the safety assessment of the cosmetic product by a scientist with a diploma in the field of pharmacy, toxicology, chemistry, food chemistry or a related discipline. Most of the safety data required for this come from testing of individual ingredients. This includes not only the overall toxicological profile of individual ingredients and their chemical structure but also the level of exposure of the user, i.e. the extent of skin contact or the duration of use.

The active peptide substances, Dermatopoietin® and Hexapeptide 18, as well as the final products were rigorously studied in a series of dermatological tests:

Acute Oral Toxicity Test
Iritation and Corrosivity Test
Skin Sensation Test
Dermal/Precutaneous Absorbtion Test
Repeated Dose Toxicity Test
Mutagenicity/Genoxicity Test

// We can also provide you a comprehensive safety assessment and preparation of a safety data sheet based on the available test results following the EU Cosmetic Directive.

 

1.1 History

1.2 How it works?

1.3 Safety

1.4 Efficacy

1.5 Hexapeptide 18